{"ticker": {"uuid": "6257a26a-c423-4c76-90da-e3d7b4205099", "symbol": "VIRO", "name": "ViroGates A/S", "exchange": "CPH", "country": "DK", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Resolutions from the Annual General Meeting of ViroGates A/S", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOckZKNFU1TWdkWWdlbFIzRUxURE9aUllnVmxLMFBNdm4tSXhJMXFKYWhiOVIyamtVenI1THd6Z2gwZHltbndwNmt2dFg5blYzby1JWVhFaUkwQzlfclhUblZLV0NBeUNYdEVkYU90RHlUWjAzZHFFZ0ZxOTdtWGstTjE3eE0yaUFNQ0JZLVRiYzdiYmdWYnd6ODRZZTB3cE5fUW1tRGNSY1NqcEJTYV90a09uTjBPSXlUMC1YREVEclJvQk9M?oc=5", "source_name": "TradingView", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ViroGates announces the commercial launch of its suPARnostic\u00ae POC+ product", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9qb0xtd3FaS0d3UDdJV2E0ZGZZdWxBRk8xSjg2SnUzTmIzWHlkbXpnc2RadldDVW1RSk94SGVQcFNtbUNQelJXYk9aWDVqWjFnNVRpSUFwaV9GaDRwLW5QaW10aTR3TXgwSXpZLUprbGhBbHp4WTA0?oc=5", "source_name": "Via Ritzau", "published_at": "2023-02-24T08:00:00+00:00", "published_display": "24 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ViroGates announces CE-IVD approval for suPARnostic\u00ae TurbiLatex on the Roche Diagnostics cobas\u00ae Pure and Pro instrument platforms", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFBocjBqdGR6MmIzSjlkY0ZqUDE0WXNnUWFWR252QjljLUtCNTVxaEZIdWlJUkJhcWpTT2xueEo5RjcyYkhrY29VX3MyaGNHY3VOcW81eFNLa0h6bGxPQzB0V3hhQmQ1elhvc255NWdXQ1NQNXRVQ1BF?oc=5", "source_name": "Via Ritzau", "published_at": "2023-02-06T08:00:00+00:00", "published_display": "06 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Resolutions from the Annual General Meeting of ViroGates A/S", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOckZKNFU1TWdkWWdlbFIzRUxURE9aUllnVmxLMFBNdm4tSXhJMXFKYWhiOVIyamtVenI1THd6Z2gwZHltbndwNmt2dFg5blYzby1JWVhFaUkwQzlfclhUblZLV0NBeUNYdEVkYU90RHlUWjAzZHFFZ0ZxOTdtWGstTjE3eE0yaUFNQ0JZLVRiYzdiYmdWYnd6ODRZZTB3cE5fUW1tRGNSY1NqcEJTYV90a09uTjBPSXlUMC1YREVEclJvQk9M?oc=5", "source_name": "TradingView", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ViroGates announces the commercial launch of its suPARnostic\u00ae POC+ product", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9qb0xtd3FaS0d3UDdJV2E0ZGZZdWxBRk8xSjg2SnUzTmIzWHlkbXpnc2RadldDVW1RSk94SGVQcFNtbUNQelJXYk9aWDVqWjFnNVRpSUFwaV9GaDRwLW5QaW10aTR3TXgwSXpZLUprbGhBbHp4WTA0?oc=5", "source_name": "Via Ritzau", "published_at": "2023-02-24T08:00:00+00:00", "published_display": "24 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ViroGates announces CE-IVD approval for suPARnostic\u00ae TurbiLatex on the Roche Diagnostics cobas\u00ae Pure and Pro instrument platforms", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFBocjBqdGR6MmIzSjlkY0ZqUDE0WXNnUWFWR252QjljLUtCNTVxaEZIdWlJUkJhcWpTT2xueEo5RjcyYkhrY29VX3MyaGNHY3VOcW81eFNLa0h6bGxPQzB0V3hhQmQ1elhvc255NWdXQ1NQNXRVQ1BF?oc=5", "source_name": "Via Ritzau", "published_at": "2023-02-06T08:00:00+00:00", "published_display": "06 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 62, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 66, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 10.2, "latest_week": "2026-06-19", "one_week_move": 1.0, "four_week_move": -6.4, "twelve_week_move": -10.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.030439, "market_dynamics_buy_signal": false, "relative_strength": -13.629112, "fair_value_gap": -0.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 40.108, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.0% over one week, -6.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Via Ritzau", "count": 2}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "66/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.0% over one week, -6.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Resolutions from the Annual General Meeting of ViroGates A/S"}], "updated_at": "2026-06-22T21:14:23.399431+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}